TRIL activation in ductal carcinoma in situ.

Innate immune changes in the breast during transformation are incompletely defined. We demonstrate here activation of TRIL in ductal carcinoma in situ in vivo.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-10-29
DOI
https://doi.org/10.5281/zenodo.23771561
Primary Topic
Immune Response and Inflammation
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

TRIL activation in ductal carcinoma in situ.

Shahan Mamoor
3 links
Zenodo (CERN European Organization for Nuclear Research)
Immune Response and Inflammation
preprint

TRIL activation in ductal carcinoma in situ.

Shahan Mamoor
preprint en

Abstract

Innate immune changes in the breast during transformation are incompletely defined. We demonstrate here activation of TRIL in ductal carcinoma in situ in vivo.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Immune Response and Inflammation
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
TRIL activation in ductal carcinoma in situ. — Shahan Mamoor · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS